国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
临床药师参与1例冠心病伴假性血小板减少症诊治病例分析
Clinical Pharmacist Participates A Case Analysis of Diagnosis and Treatment of Coronary Heart Disease with Pseudothrombocytopenia
  
DOI:
中文关键词:  临床药师  冠心病  抗血小板药物  EDTA依赖性  假性血小板减少
英文关键词:Clinical pharmacist  Coronary heart disease  Antiplatelet drugs  EDTA dependence  Pseudothrombocytopenia
基金项目:
作者单位
黄燕1 陈洁霞2 汪燕燕1 许杜娟1 夏泉1 安徽医科大学第一附属医院1.药剂科2.老年心内科 合肥 230001 
摘要点击次数: 1270
全文下载次数: 490
中文摘要:
      摘 要抗血小板药物在冠心病患者的治疗中十分重要,但伴血小板重度减少往往限制了抗血小板药物的应用。因此,临床中应及时准确辨别血小板减少的原因以指导临床抗血小板药物的应用。本案例中临床药师通过分析1例老年冠心病患者出现血小板减少的原因,排除药源性血小板减少,明确为EDTA依赖性假性血小板减少症,及时恢复抗血小板治疗,避免误停抗血小板药物而导致心血管不良事件的发生。
英文摘要:
      ABSTRACT Antiplatelet agents are vital to the treatment of patients with coronary heart disease, while patients with severely reduced platelet could be limited the application of antiplatelet agents. Therefore, we should identify the cause of thrombocytopenia timely and accurately to guide the clinical application of antiplatelet agents. In this case, clinical pharmacist analysized the reasons of thrombocytopenia in an elderly patient with coronary heart disease by pharmaceutical knowledge. He cleared the reason was the dependence of EDTA pseudo thrombocytopenia, instead of drug-induced thrombocytopenia, and restored antiplatelet therapy in time, avoiding mistake stopping antiplatelet agents which could result in the occurrence of cardiovascular adverse events.
查看全文  查看/发表评论  下载PDF阅读器
关闭